Home/Filings/5/0001492839-14-000001
5//SEC Filing

WOUND MANAGEMENT TECHNOLOGIES, INC. 5

Accession 0001492839-14-000001

$SMTICIK 0000714256operating

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:07 PM ET

Size

10.6 KB

Accession

0001492839-14-000001

Insider Transaction Report

Form 5
Period: 2013-12-31
Lutz Robert Jr.
DirectorPresident and CEO
Transactions
  • Award

    Series D Preferred Stock

    2013-02-15+6,0006,000 total
    Common Stock (6,000,000 underlying)
  • Other

    Warrant

    2013-02-15+3,000,0000 total
    Exercise: $0.15From: 2012-08-17Exp: 2017-03-31Common Stock (3,000,000 underlying)
  • Purchase

    Series C Preferred Stock

    2013-11-12$70.00/sh+3,257$227,9903,257 total
    Common Stock (3,257,000 underlying)
Footnotes (2)
  • [F1]In conjunction with his agreement to the cancellation of warrants for the purchase of 3,000 shares of the issuer's common stock, the reporting person received,pursuant to a fully vested grant approved by the issuer's board of directors, 6,000 shares of the issuer's Series D Preferred Stock.Each share of Series D Preferred Stock will automatically be converted into 1,000 shares of the issuer's common stock upon effectiveness of an increase in the authorized number of shares of common stock from 100,000,000 to 250,000,000.
  • [F2]Each share of Series C Preferred Stock is convertible into 1,000 shares of the issuer's common stock, subject to the effectiveness of an increase in the authorized number of shares of common stock from 100,000,000 to 250,000,000.

Issuer

WOUND MANAGEMENT TECHNOLOGIES, INC.

CIK 0000714256

Entity typeoperating
IncorporatedTX

Related Parties

1
  • filerCIK 0000714256

Filing Metadata

Form type
5
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:07 PM ET
Size
10.6 KB